Rapid Resolution of Erosive Psoriatic Juvenile Idiopathic Arthritis With Anti-Tumor Necrosis Factor Therapy

被引：0
|
作者：
Felix, Mario David [1 ]
Ostrov, Barbara E. [2 ]
机构：
[1] Albany Med Coll, Bernard & Millie Duker Childrens Hosp, Dept Pediat, Internal Med Pediat Program, Albany, NY 12208 USA
[2] Albany Med Coll, Bernard & Millie Duker Childrens Hosp, Dept Pediat, Div Pediat Rheumatol, Albany, NY 12208 USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2021年 / 27卷 / 8S期
关键词：
D O I：
10.1097/RHU.0000000000001602
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S688 / S689
页数：2
相关论文
共 50 条
  • [41] Pilot study of chimeric monoclonal anti-tumor necrosis factor alpha anti-body (infliximab) with methotrexate in polyarticular juvenile idiopathic arthritis
    Chaturvedi, VP
    ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3421 - 3421
  • [42] Anti-tumor necrosis factor a blockade in the treatment of juvenile spondylarthropathy
    Tse, SML
    Burgos-Vargas, R
    Laxer, RA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (07): : 2103 - 2108
  • [43] Erratum to: Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients
    Gianluigi Mazzoccoli
    Incoronata Notarsanto
    Gennaro Davide de Pinto
    Mariangela Pia Dagostino
    Angelo De Cata
    Giuseppe D’Alessandro
    Roberto Tarquini
    Gianluigi Vendemiale
    Internal and Emergency Medicine, 2011, 6 : 97 - 97
  • [44] Tuberculosis infection versus anti-tumor necrosis factor therapy: screening challenges in psoriatic patients
    Solovan, Caius
    Chiticariu, Elena
    Timofte, Adelina
    Stoia-Djeska, Irina
    JOURNAL OF DRUG ASSESSMENT, 2012, 1 (01) : 65 - 67
  • [45] Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor α synthesis
    Ulfgren, AK
    Andersson, U
    Engström, M
    Klareskog, L
    Maini, RN
    Taylor, PC
    ARTHRITIS AND RHEUMATISM, 2000, 43 (11): : 2391 - 2396
  • [46] High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy
    Mor-Vaknin, Nirit
    Rivas, Miguel
    Legendre, Maureen
    Mohan, Smriti
    Yuanfan, Ye
    Mau, Theresa
    Johnson, Anne
    Huang, Bin
    Zhao, Lili
    Kimura, Yukiko
    Spalding, Steven J.
    Morris, Paula W.
    Gottlieb, Beth S.
    Onel, Karen
    Olson, Judyann C.
    Edelheit, Barbara S.
    Shishov, Michael
    Jung, Lawrence K.
    Cassidy, Elaine A.
    Prahalad, Sampath
    Passo, Murray H.
    Beukelman, Timothy
    Mehta, Jay
    Giannini, Edward H.
    Adams, Barbara S.
    Lovell, Daniel J.
    Markovitz, David M.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (04) : 594 - 605
  • [47] ANTI-TUMOR THERAPY BY INDUCTION OF ENDOGENOUS TUMOR NECROSIS FACTOR
    KATO, M
    KAKEHI, R
    SOMA, GI
    GATANAGA, T
    MIZUNO, D
    LANCET, 1985, 2 (8449): : 270 - 270
  • [48] Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action
    Feldmann, M
    Brennan, F
    Paleolog, E
    Taylor, P
    Maini, RN
    EUROPEAN CYTOKINE NETWORK, 1997, 8 (03) : 297 - 300
  • [49] Anti-tumor necrosis factor α therapy and the risk of lymphoma in rheumatoid arthritis:: No clear answer
    Symmons, DPM
    Silman, AJ
    ARTHRITIS AND RHEUMATISM, 2004, 50 (06): : 1703 - 1706
  • [50] Graves' Disease, Rheumatoid Arthritis, and Anti-Tumor Necrosis Factor-α Therapy Reply
    van Lieshout, Antoine W. T.
    Creemers, Marjonne C. W.
    Radstake, Timothy R. D. J.
    Elving, Lammy D.
    van Riel, Piet L. C. M.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (02) : 450 - 450
12345